DCF — UAB MEDICAL WEST
Enterprise Value: $-274.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-274.7M
Enterprise Value
$-86.1M
PV of Cash Flows
$-188.7M
PV of Terminal Value
$-303.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $147.0M | $-17.6M | -12.0% | $-23.8M | $-21.6M |
| Year 2 | $151.4M | $-16.6M | -11.0% | $-23.0M | $-19.0M |
| Year 3 | $155.9M | $-15.5M | -10.0% | $-22.1M | $-16.6M |
| Year 4 | $160.6M | $-15.2M | -9.0% | $-22.0M | $-15.0M |
| Year 5 | $165.4M | $-15.2M | -9.0% | $-22.2M | $-13.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-274.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$142.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12455205365877683
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5